Support for Patients and Communities Reauthorization Act of 2025

Floor Speech

Date: June 4, 2025
Location: Washington, DC


BREAK IN TRANSCRIPT

Mr. BRESNAHAN. Mr. Chair, I yield myself such time as I may consume.

Mr. Chair, today I rise on my amendment to H.R. 2483, the SUPPORT for Patients and Communities Reauthorization Act of 2025. Opioids, like fentanyl, are incredibly dangerous. Last year, our Nation lost just over 80,000 people to drug overdoses. That is 220 per day. In my home State of Pennsylvania, someone dies of a drug overdose every 2 hours.

As we work to stop these dangerous drugs from entering the country, it is important we make available the necessary resources to reverse opioid overdoses as they happen. Emergency opioid overdose reversal drugs are a lifeline, having the ability to save so many lives. Currently, HHS regulations refer to certain name brand drugs, such as Narcan, which can limit usage of other versions that may be more readily available.

My amendment would require HHS regulations or guidance documents to include any opioid overdose reversal drug approved by the FDA when referring to these emergency drugs. This will expand and ensure better access to these lifesaving drugs.

I lost my 16-year-old cousin to a drug overdose. It is incredibly important to me that we are not limiting access to these resources.

By adjusting current regulations and language, we are protecting our children, our families, and our communities. I encourage my colleagues on both sides of the aisle to save lives and support this amendment.

BREAK IN TRANSCRIPT

Mr. BRESNAHAN. Mr. Chair, in closing, I urge my colleagues to vote ``yes'' on this amendment, and I yield back the balance of my time.

BREAK IN TRANSCRIPT


Source
arrow_upward